← k3vl4r
Log inGet started →

IOVA (Iovance Biotherapeutics) Price Forecast

AI-generated price forecast for Iovance Biotherapeutics (IOVA) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads IOVA as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 7.50. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

7.50

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

IOVA forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-52.25%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called IOVA's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest IOVA news

From the market-news feed the forecasts are read against.

  • Iovance Biotherapeutics Targets 2027 Lung Cancer Filing as AMTAGVI Sales Climb · Yahoo · Nov 16
  • Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene Editing ... · Yahoo · Nov 13
  • Iovance Biotherapeutics to Present at Upcoming Conference · Yahoo · Nov 12
  • CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge? · Yahoo · Nov 12
  • Barclays, Deutsche Bank Reveal Stakes In Retail-Favorite Cancer Stocks SLS, IBRX And IOVA — Geode Adds More · Yahoo · Nov 9

🔒

See the full IOVA forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

IOVA forecast — frequently asked

Will IOVA go up?

K3vl4r's calibrated AI forecast currently reads IOVA as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the IOVA price prediction for 2026?

K3vl4r's model projects IOVA toward $3.60 over the next ~4 weeks, a -52.3% move from $7.55. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

AGIOVIRGILDNTLANBIXBEAMTMDXBNTXBIIBJAZZIRWDPRTAEDITCRBU

Will IOVA reach…?

Will IOVA reach $10.00?Will IOVA reach $20.00?Will IOVA reach $25.00?Will IOVA reach $50.00?

Or see the full IOVA price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare IOVA

IOVA vs AGIOIOVA vs VIRIOVA vs GILDIOVA vs NTLAIOVA vs NBIXIOVA vs BEAM

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.